Upstream Bioprocessing Market by Product (Cell Culture Products, Bioreactors/Fermenters, Filters, Bags & Containers, Bioreactors Accessories and Others); by Workflow (Cell Culture, Media Preparation, and Cell Separation); by Mode (Outsourced and In-house): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Global demand for upstream bioprocessing market was valued at approximately USD 4.58 billion in 2018, and is expected to generate revenue of around USD 10.81 billion by end of 2025, growing at a CAGR of around 13.2% between 2019 and 2025.

17-Oct-2019 | Number of pages: 126 | Report Code: ZMR-4889 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the upstream bioprocessing market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the upstream bioprocessing market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the upstream bioprocessing market on a global as well as regional level.

In order to give the users of this report a comprehensive view on the upstream bioprocessing market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the upstream bioprocessing market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the upstream bioprocessing market on global and regional basis.

The study provides a decisive view on the upstream bioprocessing by segmenting the market based on workflow, product, mode, and region. All the segments of upstream bioprocessing market have been investigated based on current and forecast demand and trends and the market is forecasted from 2019 to 2025.

Bioprocessing deals with use of living cells (bacteria, animal cells, plat cells) or their components (chloroplasts, enzymes etc.) to obtain desired products. Bioprocess is mainly divided into upstream and downstream processing. The upstream bioprocessing deals with complete processing right from early cell separation/isolation and cultivation, to cell banking and cell culture expansion till final harvest.

Upstream bioprocessing market is driven by increasing research activities for development of biosimilars/biomolecules, small therapeutic peptide and monoclonal antibodies. Increasing chronic disease prevalence across the globe is another major factor that is propelling the growth of upstream bioprocessing market. Need for process optimization and contamination free, safe and efficient production of biomolecules augment the market growth. However, high cost of overall processing and production may hamper the growth of this market. Increasing research to develop novel therapeutic proteins, collaborations among major players and institutes may bring new growth opportunities in the upstream bioprocessing market.

Based on product, global upstream bioprocessing market is bifurcated into cell culture products, bioreactors/fermenters, filters, bags & containers, bioreactors accessories and others. Bioreactors/fermenters segment held largest market share in 2018 owing to increasing installations by small and large scale production. Technological advancements, process automation for cost effective, regulatory compliant and safe manufacturing has attributed to growth of bioreactors/fermenters product type segment. Cell culture products segment is expected to grow at highest CAGR over the forecast period owing to increasing demand for cell cultures with higher titer productivity to manufacture biosimilars and monoclonal antibodies (mAbs).

Based on workflow market is segmented into cell culture, media preparation, and cell separation. Cell culture workflow segment held largest market share in 2018 and expected to retain its dominance over the forecast period. Technological advancements such as small scale bioproduction using micro-bioreactors and use of bioinformatics tools, data analysis & management solutions has attributed to high growth of cell culture workflow segment.

Based on mode, upstream bioprocessing market is segmented into outsourced and in-house. In-house mode of bioprocessing held largest market share due to its cost-effectiveness, presence of large number of firms with established in-house manufacturing.

At region level, North America held largest market share of global upstream bioprocessing market in 2018. Presence of major biopharmaceutical companies, increasing investment for research and development of new biomolecules & mAbs, increasing chronic disease burden, presence of developed infrastructure are major factors that propel the market growth in this region. In 2018 Europe was second largest regional market. The growth in Europe is attributed to increasing R&D activities on biosimilar and mAbs production, increasing collaborative research by academic and research institutes with biopharmaceutical players. During the forecast period Asia Pacific will register highest growth rate for upstream bioprocessing market. This is mainly due to increasing number of players focusing on emerging market growth potential.

Major players included in the report are GE Healthcare, Thermo Fisher Scientific, Merck KGaA, Sartorius AG, Corning, Inc., Applikon Biotechnology, Eppendorf AG, PBS Biotech, Inc., Lonza, Boehringer Ingelheim, CellGenix GmbH, Patheon, Samsung BioLogics, JM BIOCONNECT, CMC Biologics, and Danaher Corporation.

The report segment of global upstream bioprocessing market as follows:

Global Upstream Bioprocessing Market: By Product

  • Bioreactors/Fermenters
  • Cell Culture Products
  • Filters
  • Bioreactors Accessories
  • Bags & Containers
  • Others

Global Upstream Bioprocessing Market: By Workflow

  • Media Preparation
  • Cell Culture
  • Cell Separation

Global Upstream Bioprocessing Market: By Mode

  • In-house
  • Outsourced

Global Upstream Bioprocessing Market: By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Related Reports

Dental Fluoride Treatment Market by Product (Toothpaste, Varnish, Gel, Mouth Rinse and Other products) and by Region: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026

Mar-2020 | Price : $ 4199.00 | Pages: 126 | Report Code: ZMR-5331 | Report Format:

The report covers forecast and analysis for the dental fluoride treatment market on a global and regional level. The study provides historic data from 2016 to 2019 along with forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the dental fluorid...Read More

Cardiac Safety Services Market by Type (Standalone and Integrated Services); Service Type (Cardiovascular Imaging, Blood Pressure Measurement, Thorough QT Studies, ECG/Holter Measurement and Other Services); by End User (Contract Research Organizations (CROs), Biopharmaceutical and Pharmaceutical Companies and Other End Users) and by Region: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026

Mar-2020 | Price : $ 4199.00 | Pages: 126 | Report Code: ZMR-5330 | Report Format:

The report covers forecast and analysis for the cardiac safety services market on a global and regional level. The study provides historic data from 2016 to 2019 along with forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the cardiac safety s...Read More

Sequencing Reagents Market: by Type (Sequencing Kits, Control Kits, Template Kits, Library Kits and Others); By Technology (Third Generation Sequencing, Next Generation Sequencing and Sanger Sequencing); by Application (Agrigenomics & Forensics, Clinical Investigation, Retypeive Health, Oncology and Other Applications); By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Academic and Research Institutes and Other End Users): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Nov-2019 | Price : $ 4199.00 | Pages: 126 | Report Code: ZMR-5006 | Report Format:

The report covers forecast and analysis for the sequencing reagents market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the sequencing reagents market a...Read More

Humanized Mouse and Rat Model Market: by Type (Humanized Rat Model and Humanized Mouse Model); by Application (Hematopoiesis, Toxicology, Neuroscience, Immunology and Infectious Diseases, Oncology and Other Applications); for Academic & Research Institutes, Contract Research Organizations and Pharmaceutical & Biotechnological Companies: Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Nov-2019 | Price : $ 4199.00 | Pages: 126 | Report Code: ZMR-5003 | Report Format:

The report covers forecast and analysis for the humanized mouse and rat model market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the humanized mouse an...Read More

Chemotherapy-Induced Myelosuppression Treatment Market by Indication (Anaemia, Neutropenia and Thrombocytopenia); by Drug Class (Thrombopoietic Agents, Erythropoietin Stimulating Agents, Iron Supplements, Growth Factors and Others); by Route of Administration (Injectable and Oral); By Distribution Channel (Retail Pharmacies, Hospital Pharmacies and Online Pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Nov-2019 | Price : $ 4199.00 | Pages: 126 | Report Code: ZMR-5000 | Report Format:

The report covers forecast and analysis for the chemotherapy-induced myelosuppression treatment market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the ...Read More

Request Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.